Skip to main content
Premium Trial:

Request an Annual Quote

Authoring After the Fact

Elsevier is doing its own investigation into whether an "Editor's Choice" article appearing in the May 2003 issue of the American Journal of Obstetrics and Gynecology was "improperly ghostwritten by a drug company promoting the product," the New York Times reports. This inquiry follows on the heels of Senator Charles Grassley (R-Iowa) saying that Wyeth commissioned the article and it was written by DesignWrite, and only after that was a physician, John Eden of the University of New South Wales, found to author the article.

The article under investigation addressed the Women's Health Initiative, which ended early when women taking Wyeth's Prempro were found to have a higher risk of developing breast cancer and  it said "any association of progesterone with breast cancer risk remains controversial."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.